The top four PBMs controlled 75% of the national PBM market in 2024, up from 70% in 2022, according to a new analysis from the American Medical Association. The analysis …
Category:
Health
-
-
Sanofi’s partnership with Regeneron Pharmaceuticals yielded Dupixent, whose approvals in multiple indications make it one of the top immunology drugs in the world. The pharmaceutical company is now trying to …
-
STAT recently reported that despite the National Institutes of Health’s All of Us Research Program persuading 98% of its nearly 750,000 participants to share their electronic health records, more than …
-
Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several …
-
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Claire Love, PwC’s global …
-
The FDA is looking to bring new members to all of its advisory committees, the independent bodies that discuss and provide input on experimental drugs, vaccines, and medical devices before …
-
Social care has always been human work that moves at the speed of trust. Food insecurity, housing instability, transportation gaps, social isolation, utility shutoffs, behavioral health needs, and caregiver strain …
-
AstraZeneca is making a $2 billion equity investment in Summit Therapeutics, a business deal that also kicks off a research collaboration that could pursue multiple drug combinations with an initial …
-
Tiny Health, a microbiome intelligence platform, announced on Tuesday that it secured $33 million in Series B funding. The Austin, Texas-based company offers gut microbiome tests for adults, babies and …
-
Unite Us and Instacart announced Tuesday that they are partnering to connect healthcare organizations’ care coordination efforts with grocery benefits, with the aim of making food-as-medicine programs easier to launch …